Novel Oral Nanoparticle Formulation of Sustained Release Naloxone with Mild Withdrawal Symptoms in Mice-Reference-Cited by-同舟云学术

Novel Oral Nanoparticle Formulation of Sustained Release Naloxone with Mild Withdrawal Symptoms in Mice

Published:2020-06-03 Issue:13 Volume:11 Page:1955-1964
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Madison Caitlin A.¹,Arora Meenakshi²,Kumar M. N. V. Ravi²^ORCID,Eitan Shoshana¹^ORCID

Affiliation:

1. Behavioral and Cellular Neuroscience, Department of Psychological and Brain Sciences, Texas A&M University, 4235 TAMU, College Station, Texas 77843, United States

2. Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M University, College Station, Texas 77843, United States

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.0c00141

Reference55 articles.

1. Characteristics of Opioid Prescriptions in 2009

2. The Neurobiology of Opiate Reinforcement

3. Rates of opioid misuse, abuse, and addiction in chronic pain

4. Muhuri, P. K., Gfroerer, J. C., and Davies, M. C. (2013) Associations of Nonmedical Pain Reliever Use and Initiation of Heroin Use in the United States. CBHSQ Data Rev.; SAMHSA https://www.samhsa.gov/data/sites/default/files/DR006/DR006/nonmedical-pain-reliever-use-2013.htm (Accessed January 31, 2020).

5. Pain Management and the Opioid Epidemic

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology-Enhanced Naloxone and Alternative Treatments for Opioid Addiction;ACS Pharmacology & Translational Science;2024-05-27

2. Are carfentanil and acrylfentanyl naloxone resistant?;Frontiers in Psychiatry;2024-02-20

3. Promising biomedical subcutaneous delivery system in opioid disaccustom process: In vitro/in vivo evaluation of naloxone microparticles on antagonist effect of morphine;International Journal of Pharmaceutics;2023-03

4. Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery;Pharmaceutics;2023-02-23

5. Restoring the neuroprotective capacity of glial cells under opioid addiction;Addiction Neuroscience;2022-12